Fusnote
1. Analyse and Bewertung der Unabhängigkeit von Selbsthilfegruppen/-organisationen bzw. Patienten and Patientinnengruppen/-organisationen am Beispiel ausgesuchter Krankheitsbereiche,” Study by K. Schubert, G. Glaeseke, 2005., Bremen; navedena u: “Wer soll das bezahlen, wer bat so viel Geld?” od Magnus Heiera, Frankfurter Allgemeine Sonntagszeitung, 12.03.2006., Nr. 48/str. 75. na Internetu: www.faz.net/s/Ru-b8E1390D3396F422B869A49268EE3F15C/Doc~E3EC7A0F2E2 724EFAABC18DB81A452961~ATp1~Ecommon~Scontent.html (na njemačkom) *
2. Vidi: http://edition.cnn.com/2006/HEALTH/03/15/uk.clinical/index.html?section=cnn _latest
3. Vidi: Guardian Unlimited, 09.17.2000. © Guardian Newspapers Limited 2006.
www.guardian.co.uk/Archive/Article/0,4273,4064664,00.html
4. Slučaj je objavljen i prodan medijima. Na primjer: www.rense.com/general66/tradesecret.htm
5. Analyse and Bewermng der Unabhängigkeit von Selbsthilfegruppen/-organisationen bzw. Patienten and Patientinnengruppen/-organisationen am Beispiel ausgesuchter Krankheitsbereiche, Studie von K. Schubert,
6. Glaeseke, 2005., Bremen objavljeno u Frankfurter Allgemeine Sonntagszeitung (na njemačkom), 12.03.2006., Nr. 48/ Str. 75., na Internetu: www.faz.net/s/Rub8E1390D3396F422B869A49268EE3F15C/Doc~E3EC7A0F2E2724EFAABC18DB81A452961~ATp1~Ecommon~Scontent.html * PANORAMA Nr. 647 from 11.25.2004. Može se pročitati na Internetu: http://daserste.ndr.de/container/file/t_cid-2856592_.pdf *
7. www.dradio.de/dlf/sendungen/dossier/479955/ (na njemačkom)
8. Richard Smith, Medical journals and pharmaceutical companies: uneasy bedfellows” u British Medical Journal, 31. svibanj 2003; može se pročitati na: www.bmj.com/cgi/content/full/326/7400/1202?maxtoshow=&HITS=10&hits=10 &RESULTFORMAT=&fulltext=benoxaprofen&searchid=1&FIRSTINDEX=O&resourcetype=HWCIT
9. isto
10. isto
11. isto
12. Taj razvoj Lillyjevih internih komunikacija je naveo Joyce C, Lesser F. “Opren deaths kept secret, admits Lilly” u the New Scientist, 29. kolovoz 1985.
13. isto
14. Bernhard M. Lasotta: Beschreibung and Vergleich der Spontanerfassungssysteme rur unerwünschte Arznei mittelwirkungen (Dissertation 1999.); vidi: www.lasotta.de/Dissertation.pdf (na njemačkom) *
15. Joyce C, Lesser F. “Opren deaths kept secret, admits Lilly” u New Scientist, 29. kolovoz 1985.
16. isto
17. isto
18. isto
19. isto
20. isto
21. isto
22. isto
23. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, i dr. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Eng! J Med 2000; 343: 1520-8
24. Paul A Dieppe, Shah Ebrahim, Richard M Martin i Peter Jüni: “Lessons from the withdrawal of rofecoxib” u the British Medical Journal od 16. listopad 2004.; dostupno na: www.bmj.com/cgi/content/full/329/7471/867
25. isto
26. Prof. Dr. med. Bruno Müller-Oerlinghausen, Predsjednik komisije za lijekove njemačkog liječničkog društva (AkdÄ) i izdavač “Arzneiverordmmg in der Praxis” od 21. siječnaj 2005. u Berlinu. Zitiert in: Richter-KuhImann, Eva A. Arzneimittelsicherheit: Vernachlässigtes Waisenkind in Deutsches Ärzteblatt 102, Ausgabe 5 vom 04.02.2005, Seite A-252 / B-208 / C-195 (na njemačkom)
27. isto
28. www.tga.gov.au/media/2007/070811-lumiracoxib.htm
29. Paul A Dieppe, Shah Ebrahim, Richard M Martin i Peter Jüni: “Lessons from the withdrawal of rofecoxib” u the British Medical Journal 16. listopad 2004.; dostupno na: www.bmj.com/cgi/content/full/329/7471/867
30. Objavljeno u: Richter-Kuhlmann, Eva A. Arzneimittelsicherheit (na njemačkom): Vernachlässigtes Waisenkind Deutsches Ärzteblatt 102, Izdanje 5 od 04.02.2005., strana A-252 / B-208 / C-195
31. vidi: Pharmabosse jammem beim Kanzler (na njemačkom) www.taz.de/pt/2004/07/07/a0115.1/text.ges,1
32. vidi: www.interbrand.com/portfolio_details.asp?portfolio=1670&language=ID= *
33. Koch, Klaus: Pharmamarketing: Millionen für die Meinungsbildner: Deutsches Ärzteblatt 98, Ausgabe 39 vom 28.09.2001, Seite A-2484 / B-2122 / C-1987 POLITIK: Medizin-report (na njemačkom) http://www.aerzteblatt.de/v4/archiv/artikel.asp?id=28801
34. Martin Lindner 2006: Versuchskaninchen” in DIE ZEIT, 31.08.2006, Nr. 36 (na njemačkom)
35. Navedeno u članku iz English Guardian “They said it was safe” od subote 30. listopada 1999; dostupno na: www.guardian.co.uk/weekend/story/0,,258000,00.html
36. vidi Heide Neukirchen in “Der Pharma Report”, Droemer, 2005 (na njemačkom)
37. www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=407652
38. U međuvremenu je Fluoxetine otkriven u brazilskim dijetnim tabletama. Zovu se Emagrece Sim i Herbathin. FDA upozorava na njihovo korištenje u siječnju 2006.
39. Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry Lisa Cosgrovea, Sheldon Krimskyb, Manisha Vijayaraghavana, Lisa Schneidera Psychotherapy and psychosomatics 2006;75:154-160 (DOI: 10.1159/000091772)
40. www.bukopharma.de/Pharma-Brief/PB-Archiv/1998/phbf9802.html (na njemačkom)
41. isto
42. isto
43. isto
44. www.bukopharma.de/Pharma-Brief/PB-Archiv/1998/phbf9802.html (na njemačkom)
45. Sara Hoffman Jurand “Lawsuits over antidepressants claim the drug is worse than the disease”. Dostupno na: www.baumhedlundlaw.com/SSRIs/Lawsuits%20over%20antidepressants.htm *
46. “They said it was safe” Guardian from Saturday, October 30, 1999; dostupno na: www.guardian.co.uk/weekend/story/0,,258000,00.html
47. Lilly was sentenced for incorrect information on its package inserts for Benoxaprofen. Vidi na: www.zmagsite.zmag.org/May2004/levine0504.html *
48. Sarah Boseley, “They said it was safe” Guardian from Saturday, October 30, 1999, dostupno na: www.guardian.co.uk/weekend/story/0,,258000,00.html
49. isto
50. isto
51. Peter R Breggin and Ginger Ross Breggin, 1994: TaIking back to Prozac, St Martin’s Press, citirano s interneta: www.sntp.net/prozac/breggin_prozac_2.htm
52. isto
53. isto
54. isto
55. isto
56. isto
57. isto
58. isto
59. Članak od 14.veljače 2006. u “Ärztliche Praxis”:
www.aerztlichepraxis.de/artikel_gynaekologie-schwangerschaft_ssri-1139935991.htm (na njemačkom) *
60. isto
61. izvor: interni Lilly memorandum u mom posjedu
62. Peter R. Breggin and Ginger Ross Breggin, 1994: Talking back to Prozac, St Martin’s Press
63. vidi arznei- telegramm I/2005 (na njemačkom)
64. vidi: www.Lilly.co.uk
65. J.R.Lacasse, J. Leo, Serotonin and Depression – A Disconnect between the Advertisements and the Scientific Literature, November 8, 2005, PLoS Medicine Vol. 2, No.12, vidi:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0020392,
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277931
66. isto
67. Brojke i citat je iz njegovog govora u Tallahasseeju, Florida održanom 8.09.2006., dostupno na:
http://www.phrma.org/next-small-thing-update-biomedical-revolution
68. www.en.wikipedia.org/wiki/Fluoxetine, www.de.wikipedia.org/wiki/Fluoxetin
69. Detalji slučaja Wesbecker su dostupni na: www.lectlaw.com/filesh/zbk03.htm i http://zmagsite.zmag.org/May2004/levine0504.html *
70. Guardian from Saturday, October 30, 1999 “They said it was safe”, dostupno na: http://www.guardian.co.uk/theguardian/1999/oct/30/weekend7.weekend1
71. Peter Breggin, FDA Press Conference September 2004
72. Dr. David Healy, kao svjedok u procesu Nick-Schulz-Solce i Hans Weber, na sudskoj raspravi Lilly vs Fentress, dostupno na: www.ahrp.org/risks/healy/SSRIrisks0803.php
73. www.emea.europa.eu/pdfs/human/press/pr/20255406en.pdf
74. isto
75. www.transparency.de/2006-01-19-Gesandheit.861.0.html?&contUid1576 (na njemačkom)
76. BGA from July 26, Geschaftszeichen GV 7-7251-01-18857/8) – citirano uz dozvolu Dr. Ernst v. Kriegstein (na njemačkom)
77. Lancet, 1980; ii: 398-401; citirano iz DIABETES THE SCANDAL OF HUMAN INSULIN © What Doctors Don’t Tell You, dostupno na internetu: www.healthy.net/scr/article.aspx?Id=2826
78. isto
79. isto
80. www.healthy.net/scr/Article.aspx?Id=2826&xcntr=2
81. Brendan Coyne, 2005 “Drug Co. Admits Guilt in Off-label Marketing Case” u: The New Standard. Dostupno na internetu: www.newstandardnews.net/content/index.cfm/items/2699 *
82. isto
83. isto
84. Bernadette Tansey, 2005: “HARD SELL: How Marketing Drives the Pharmaceutical Industry,” dostupno na:
http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2005/05/01/MNG4TCID0J1.DTL
85. Erika Kelton “Sales tactics, whistleblowers and qui tam lawsuits in the pharmaceutical industry”: www.cafepharma.com/quitam.asp
86. Citirano iz: Article from May 13, 2004 in The New Standard: “Suit: Pfizer bribed doctors to prescribe drug for unapproved uses” dostupno na: www.newstandardnews.net/content/index.cfm/items/352
87. www.nytimes.com/2006/08/30/business/30drug.html?ex=1314590400&en=a9304d7a40352394&ei=5088&partner=rssnyt&emc=rss
88. Citirano iz: www.zdf.de/ZDFde/in-halt/26/0,1872,2083034,00.html (na njemačkom) *
89. J.R.Lacasse, J. Leo, Serotonin and Depression – A Disconnect between the Advertisements and the Scientific Literature, November 8, 2005, PLoS Medicine Vol. 2, No. 12, vidi.: www.plosmedicine.org
90. Vidi arznei-telegrammI/2005 (na njemačkom)
91. www.24-7pressrelease.com/view_press_release.php?rID=11216 i www.24-7pressrelease.com/view_press_release.php?rID=21052&tf7sid=af63601bf350e2d39c51e62a23c63087
92. isto
93. www.drgreene.org/body.cfm?id=21&action=detail&ref=1246
94. www.atomoxetine.info
95. www.dradio.de/dlf/sendungen/sprechs-tunde/431640/%20 (na njemačkom) *
96. Na primjer: www.adders.org/news109.htm
97. J. R. Lacasse, J. Leo, Serotonin and Depression – A Disconnect between the Advertisements and the Scientific Literature, November 8,2005, PLoS Medicine Vol. 2, No. 12, vidi: www.plosmedicine.org
98. The information surrounding the Texas project and Allen Jones are from: www.bmj.com/cgi/content/full/328/7454/1458 i http://psychrights.org/Drugs/AllenJonesTMAPJanuary20.pdf
99. BMJ 2005; 331: 592 (September 17,2005)
100. www.psychsearch.net/teenscreen.html
101. Peter R. Breggin and Ginger Ross Breggin, 1994: Talking back to Prozac, St Martin’s Press, citirano iz: www.sntp.net/prozac/breggin_prozac_2.htm
102. www.psychsearch.net/teenscreen.html
103. Journal of the American Academy of Child Adolescent Psychiatry 2002
104. www.bmj.com/cgi/content/full/331/7521/906?maxtoshow=&HITS=10&hit =10&RESULTFORMAT=&fulltext=TeenScreen&searchid=1&FIRSTINDEX=O&resourcetype=HWCIT
105. Spiegel Online, January 6,2006, www.spiegel.de/wissenschaft/mensch/0,1518,393609,00.html (na njemačkom)
106. http://ahrp.blogspot.com/2007/01/zyprexa-cat-out-bag-new-legal-motion.html
107. Članak Gardinera Harrisa u New York Timesu, 18.12.2003., npr. http://psychrights.org/articles/LevineLillyandBush.htm
108. http://query.nytimes.com/gst/fullpage.html?res=9C02E01D7163FF93BA25751C1A9659C8B63 *
109. http://www.mindfreedom.org/as/act/us/psychrights/nytimes-vs-eli-lilly/states-study-marketing-of-lilly-pill/?searchterm=states-study-marketing-of-Lilly-pill
110. Ovo i sve druge informacije o Zyprexi su, u slučaju da nije drukčije napomenuto, uzete odavde: www.opednews.com/articles/genera_evelyn_p_070205_nobody_buys_Lilly_s_.htm
111. Arznei-telegramm od 13. veljače 2004.; dostupno na engleskom: www.newstarget.com/001895.html
112. www.transparency.de/2006-05-1116_Gesundheit.911.0.html (na njemačkom)
113. läkemedelsvärlden “Welt der Arzneimittel” December, 2006 (na njemačkom)
114. www.transparency.de/2006-01-19-Gesundheit.861.0.html?& contUid1576 (na njemačkom)
115. http://www.prnewswire.com/cgi-bin/micro_stories.pl?ACCT=916306&TICK=LLY&STORY=/www/story/01-04-2007/0004499787&EDATE=Jan+4,+2007

* internetske stranice označene zvjezdicom nisu bile aktivne u trenutku izdavanja hrvatskog izdanja knjige, za pronalaženje moguće je pomoći si unošenjem ključnih riječi putem internetskih tražilica